SCHEMBL29940518

SCHEMBL29940518

COc1ccc2c(c1)CC(=O)CC2

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.53
DRD1 P21728 8/20 0.53
DRD5 P21918 8/20 0.53
DRD2 P14416 8/20 0.53
DRD3 P35462 8/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP11B1 P15538 1/20 0.52
CYP11B2 P19099 1/20 0.52
CYP2C19 P33261 1/20 0.52
DRD4 P21917 5/20 0.49
BCL2 P10415 1/20 0.49
CYP2A6 P11509 1/20 0.48
MAOB P27338 2/20 0.46
NOTUM Q6P988 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43307 1.00 METAP1 (0.53) METAP1DRD1DRD5DRD2DRD3
SCHEMBL227363 0.93 CYP1A2 (0.60) METAP1DRD1DRD5DRD2DRD3
Sulfurous Acid SCHEMBL6400949 0.92 CYP1A2 (0.47) METAP1DRD1DRD5DRD2DRD3
SCHEMBL3813236 0.89 DRD1 (0.52) METAP1DRD1DRD5DRD2DRD3
SCHEMBL2062199 0.89 DRD1 (0.54) METAP1DRD1DRD5DRD2DRD3
SCHEMBL4041676 0.86 METAP1 (0.58) METAP1DRD1DRD5DRD2DRD3
SCHEMBL27844091 0.84 CYP1A2 (0.49) METAP1DRD1DRD5DRD2DRD3
SCHEMBL27843792 0.84 CYP1A2 (0.49) METAP1DRD1DRD5DRD2DRD3
SCHEMBL228868 0.82 DRD1 (0.56) METAP1DRD1DRD5DRD2DRD3
SCHEMBL14172824 0.82 DRD1 (0.56) METAP1DRD1DRD5DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036628-A Iron death inhibitor, preparation method and application thereof 福建医科大学 2026-05-15 CN disclosed
CN-115594669-B Parallel ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-11-05 CN disclosed
CN-117466773-A Preparation method of eletinib intermediate 上海药坦药物研究开发有限公司 2024-01-30 CN disclosed
CN-115340523-B Compound with ALK inhibitory activity and preparation method and application thereof 盛世泰科生物医药技术(苏州)股份有限公司 2023-12-15 CN disclosed
CN-117024410-A Airotinib intermediate and preparation method thereof 上海药坦药物研究开发有限公司 2023-11-10 CN disclosed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 CN disclosed
CN-115340523-A Compound with ALK inhibitory activity and preparation method and application thereof 盛世泰科生物医药技术(苏州)有限公司 2022-11-15 CN disclosed